Rick Winningham Theravance Biopharma CEO Rating

Theravance Biopharma CEO Rick Winningham Bio

Mr. Rick E. Winningham has been the Chairman and Chief Executive Officer at Theravance Biopharma, Inc. since its spin-off from Theravance, Inc. since July 2013 and since June 2014 respectively. Mr. Winningham served as the Chief Executive Officer of Theravance Inc. from October 2001 to August 15, 2014. He served as the President of Theravance Inc. since October 2001. From 1997 to 2001, he served as the President of Bristol-Myers Squibb Oncology /Immunology /Oncology Therapeutics Network (OTN) and as the President of Global Marketing from 2000 to 2001. Along with operating responsibility for U.S. Oncology/Immunology/OTN at Bristol-Myers Squibb (BMS), he had full responsibility for Global Marketing in the Cardiovascular, Infectious Disease, Immunology, Oncology/Metabolics and GU /GI /Neuroscience therapeutic areas. During his tenure with BMS, he was associated with the development and commercialization of several major pharmaceutical products, such as Taxol???, Paraplatin???, Zerit???, Videx???, Reyataz???, and Abilify???. He serves as the Chairman of California Life Sciences Association. He serves as the Chairman of the Board of Directors of California Healthcare Institute. Mr. Winningham served as the Chairman of Theravance Inc. until October 30, 2014. He has been Lead Independent Director and Director of Jazz Pharmaceuticals Public Limited Company since 2010 and January 2012 respectively. He has been a Director of California Healthcare Institute since November 2011, OncoMed Pharmaceuticals, Inc. since June 29, 2015 and Theravance Biopharma, Inc. since July 2013. He serves as a Member of Advisory Board at NovaMed Pharmaceuticals Inc. He served as a Director of Theravance Inc. from October 2001 to October 30, 2014 and Azur Pharma Public Limited Company. He is a Member of the External Advisory Board for the College of Business and Administration and Business Hall of Fame at Southern Illinois University and holds a seat on the Advisory Council for the Keck Graduate Institute. He is also a Member of Biotechnology Industry Organization's Board of Directors and serves on the Health Section Governing Board Standing Committee on Reimbursement. Mr. Winningham holds a BS degree from Southern Illinois University and a Master's of Business Administration from Texas Christian University.

Theravance Biopharma CEO Rick Winningham At a Glance

The CEO score provides an understanding of how employees feel about the CEO’s leadership style and effectiveness at Theravance Biopharma.

Based on 3 ratings, Rick Winningham ranks right below Allergan's CEO, Brenton Saunders.

Overall, the CEO score has remained stable over the last 90 days.